AMP-activated protein kinase and energy balance in breast cancer.
Cancer growth and metastasis depends on the availability of energy. Energy-sensing systems are critical in maintaining a balance between the energy supply and utilization of energy for tumor growth. A central regulator in this process is AMP-activated protein kinase (AMPK). In times of energy deficit, AMPK is allosterically modified by the binding of increased levels of AMP and ADP, making it a target of specific AMPK kinases (AMPKKs). AMPK signaling prompts cells to produce energy at the expense of growth and motility, opposing the actions of insulin and growth factors. Increasing AMPK activity may thus prevent the proliferation and metastasis of tumor cells. Activated AMPK also suppresses aromatase, which lowers estrogen formation and prevents breast cancer growth. Biguanides can be used to activate AMPK, but AMPK activity is modified by many different interacting factors; understanding these factors is important in order to control the abnormal growth processes that lead to breast cancer neoplasia. Fatty acids, estrogens, androgens, adipokines, and another energy sensor, sirtuin-1, alter the phosphorylation and activation of AMPK. Isoforms of AMPK differ among tissues and may serve specific functions. Targeting AMPK regulatory processes at points other than the upstream AMPKKs may provide additional approaches for prevention of breast cancer neoplasia, growth, and metastasis.
Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University Chicago, IL, USA.
Hong
H
Zhao
Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University Chicago, IL, USA.
Yelda C
YC
Orhan
Department of Surgery, The First Affiliated Hospital of Nanjing Medical School Nanjing, Jiangsu, China.
Xiaoming
X
Zha
Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University Chicago, IL, USA.
Ecem
E
Esencan
Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern UniversityChicago, IL, USA; Department of Physiology, Feinberg School of Medicine, Northwestern UniversityChicago, IL, USA; Department of Pathology, Feinberg School of Medicine, Northwestern UniversityChicago, IL, USA.
Robert T
RT
Chatterton
Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University Chicago, IL, USA.
Serdar E
SE
Bulun
AMP-dependent protein kinase; Breast cancer; biguanides